HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R I Modi Selected Research

Immuvac

1/2017A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R I Modi Research Topics

Disease

1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1Disease Progression
01/2017

Drug/Important Bio-Agent (IBA)

1ImmuvacIBA
01/2017
1taxaneIBA
01/2017
1PlatinumIBA
01/2017

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2017
1Therapeutics
01/2017